Comparison of hepatocellular carcinoma risk between patients treated with glimepiride and gliclazide

J. Y. Lee; G. Kim; Y. H. Lee; B. W. Lee; B. S. Cha; C. M. Nam; E. S. Kang

doi:10.1016/j.diabet.2017.06.007

Comparison of hepatocellular carcinoma risk between patients treated with glimepiride and gliclazide

J. Y. Lee
, G. Kim
, Y. H. Lee
, B. W. Lee
, B. S. Cha
, C. M. Nam
, E. S. Kang

Yonsei University

Research output: Contribution to journal › Letter › peer-review

8 Scopus citations

Original language	English
Pages (from-to)	83-85
Number of pages	3
Journal	Diabetes and Metabolism
Volume	45
Issue number	1
DOIs	https://doi.org/10.1016/j.diabet.2017.06.007
State	Published - Jan 2019
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.diabet.2017.06.007

Cite this

@article{f4f8e3e058aa4b31b834338fd4187b86,

title = "Comparison of hepatocellular carcinoma risk between patients treated with glimepiride and gliclazide",

author = "Lee, \{J. Y.\} and G. Kim and Lee, \{Y. H.\} and Lee, \{B. W.\} and Cha, \{B. S.\} and Nam, \{C. M.\} and Kang, \{E. S.\}",

year = "2019",

month = jan,

doi = "10.1016/j.diabet.2017.06.007",

language = "English",

volume = "45",

pages = "83--85",

journal = "Diabetes and Metabolism",

issn = "1262-3636",

publisher = "Elsevier Masson s.r.l.",

number = "1",

}

TY - JOUR

T1 - Comparison of hepatocellular carcinoma risk between patients treated with glimepiride and gliclazide

AU - Lee, J. Y.

AU - Kim, G.

AU - Lee, Y. H.

AU - Lee, B. W.

AU - Cha, B. S.

AU - Nam, C. M.

AU - Kang, E. S.

PY - 2019/1

Y1 - 2019/1

UR - https://www.scopus.com/pages/publications/85026539252

U2 - 10.1016/j.diabet.2017.06.007

DO - 10.1016/j.diabet.2017.06.007

M3 - Letter

C2 - 28778564

AN - SCOPUS:85026539252

SN - 1262-3636

VL - 45

SP - 83

EP - 85

JO - Diabetes and Metabolism

JF - Diabetes and Metabolism

IS - 1

ER -

Comparison of hepatocellular carcinoma risk between patients treated with glimepiride and gliclazide

UN SDGs

Access to Document

Other files and links

Cite this